Artificial differences in Clostridium difficile infection rates associated with disparity in testing Journal Article
| Authors: | Kamboj, M.; Brite, J.; Aslam, A.; Kennington, J.; Babady, N. E.; Calfee, D.; Furuya, Y.; Chen, D.; Augenbraun, M.; Ostrowsky, B.; Patel, G.; Mircescu, M.; Kak, V.; Tuma, R.; Karre, T. A.; Fry, D. A.; Duhaney, Y. P.; Moyer, A.; Mitchell, D.; Cantu, S.; Hsieh, C.; Warren, N.; Martin, S.; Willson, J.; Dickman, J.; Knight, J.; Delahanty, K.; Flood, A.; Harrington, J.; Korenstein, D.; Eagan, J.; Sepkowitz, K. |
| Article Title: | Artificial differences in Clostridium difficile infection rates associated with disparity in testing |
| Abstract: | In 2015, Clostridium difficile testing rates among 30 US community, multispecialty, and cancer hospitals were 14.0, 16.3, and 33.9/1,000 patient-days, respectively. Pooled hospital onset rates were 0.56, 0.84, and 1.57/1,000 patient-days, respectively. Higher testing rates may artificially inflate reported rates of C. difficile infection. C. difficile surveillance should consider testing frequency. © 2018, Centers for Disease Control and Prevention (CDC). All rights reserved. |
| Keywords: | diarrhea; nonhuman; prevalence; enzyme immunoassay; hospitalization; hospital admission; clostridium difficile infection; diagnostic test; disease transmission; nucleic acid amplification; article; peptoclostridium difficile |
| Journal Title: | Emerging Infectious Diseases |
| Volume: | 24 |
| Issue: | 3 |
| ISSN: | 1080-6040 |
| Publisher: | Centers for Disease Control and Prevention |
| Date Published: | 2018-03-01 |
| Start Page: | 584 |
| End Page: | 587 |
| Language: | English |
| DOI: | 10.3201/eid2403.170961 |
| PROVIDER: | scopus |
| PMCID: | PMC5823336 |
| PUBMED: | 29460760 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 2 April 2018 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work